Role of the Immune Environment in Response to Therapy in Breast Cancer

Role of the Immune Environment in Response to Therapy in Breast Cancer
Conditions:   Breast Cancer;   ER Positive Breast Cancer;   HER2-negative Breast Cancer;   TNBC – Triple-Negative Breast Cancer
Intervention:   Other: Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
Sponsor:   Abramson Cancer Center of the University of Pennsylvania
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 1, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments